Larimar Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LRMR and other ETFs, options, and stocks.About LRMR
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia.
CEOCarole S. Ben-Maimon
CEOCarole S. Ben-Maimon
Employees65
Employees65
HeadquartersBala Cynwyd, Pennsylvania
HeadquartersBala Cynwyd, Pennsylvania
Founded2005
Founded2005
Employees65
Employees65
LRMR Key Statistics
Market cap153.03M
Market cap153.03M
Price-Earnings ratio-1.83
Price-Earnings ratio-1.83
Dividend yield—
Dividend yield—
Average volume974.40K
Average volume974.40K
High today$2.46
High today$2.46
Low today$2.28
Low today$2.28
Open price$2.32
Open price$2.32
Volume785.97K
Volume785.97K
52 Week high$11.20
52 Week high$11.20
52 Week low$1.61
52 Week low$1.61
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own LRMR. This list is generated using Robinhood data, and it’s not a recommendation.